Probiotic-based Antiviral Solutions for Environmental Remediation and Beyond

Publication ID: 24-11857581_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Probiotic-based Antiviral Solutions for Environmental Remediation and Beyond,” Published Technical Disclosure No. 24-11857581_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857581_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,581.

Summary of the Inventive Concept

The present inventive concept leverages the antiviral properties of probiotic bacteria to develop novel solutions for environmental remediation, agricultural crop protection, air purification, and aquaculture, addressing critical problems in these industries.

Background and Problem Solved

The original patent disclosed antiviral methods and compositions comprising probiotic bacterial molecules for controlling pathogenic viruses in mammals. However, the growing concern about environmental pollution, agricultural productivity, and public health has created a pressing need for innovative solutions. The present inventive concept tackles these challenges by applying the core technology to entirely new industries and use cases.

Detailed Description of the Inventive Concept

The inventive concept involves the use of secreted molecules from probiotic bacteria to combat pollution-causing viruses in waterways, soil-borne viruses in contaminated soil, airborne viruses in air purification systems, plant viruses in agricultural crops, and aquatic viruses in aquaculture. The compositions and methods described in the new claims provide a groundbreaking approach to mitigating the environmental and economic impact of viral infections in these sectors.

Novelty and Inventive Step

The present inventive concept introduces a paradigm shift by extending the antiviral properties of probiotic bacteria to non-mammalian applications, demonstrating a non-obvious and innovative leap beyond the original patent's scope.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different probiotic bacteria strains, varying compositions and formulations, and diverse delivery methods tailored to specific industries and use cases.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the environmental remediation, agriculture, air purification, and aquaculture industries, offering a unique value proposition for companies and organizations seeking innovative solutions to critical problems.

Field of Art

Microbiology, Virology, and Biotechnology with a focus on probiotic bacterial molecules and their antiviral applications across environmental and biological systems

Person of Ordinary Skill (PHOSITA) Profile

A researcher or biotechnologist with advanced degree in microbiology, expertise in probiotic bacterial interactions, viral mechanisms, and interdisciplinary applications of microbial molecules

Obviousness Rationale

A PHOSITA would recognize the inherent extensibility of probiotic bacterial antiviral molecules across different environmental contexts. The source patent establishes the fundamental principle of using probiotic-derived peptides to combat viral infections in mammals, which naturally suggests broader applications in other biological and environmental systems. The technical mechanism of viral interference through bacterial secreted molecules remains consistent across the PTD's proposed variations, representing a predictable extrapolation of the original patent's core scientific insight.

Obvious Combinations & Variations

Source Patent Element
Antiviral peptides secreted by Lactobacillus and other probiotic bacteria
PTD Variation
Applying identical peptide mechanisms to environmental viral challenges in waterways, soil, and agricultural systems
Obviousness Reasoning
Known technique of extending microbial molecular interactions across different biological contexts, representing a predictable scientific progression
Source Patent Element
Specific probiotic bacterial strains with antiviral properties
PTD Variation
Utilizing similar bacterial strain selection principles for non-mammalian viral remediation strategies
Obviousness Reasoning
Finite set of known probiotic strains with demonstrable viral interference capabilities, making cross-domain application a routine design choice
Source Patent Element
Method of administering probiotic-derived molecules to combat viral infections
PTD Variation
Adapting administration techniques for environmental and industrial viral control systems
Obviousness Reasoning
Established molecular delivery principles can be readily modified for different target environments using standard biotechnological approaches
Source Patent Element
Peptide-based viral interference mechanism
PTD Variation
Expanding viral interference concept to aquaculture and agricultural viral challenges
Obviousness Reasoning
Fundamental molecular interaction principles remain consistent across biological domains, representing an obvious technological extension
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857581, a person having ordinary skill in the art would find the environmental and non-mammalian viral remediation techniques disclosed herein to be obvious variations of the fundamental probiotic antiviral molecular mechanisms, thereby rendering subsequent claims of novelty invalid under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,581
TitleAntiviral methods and compositions comprising probiotic bacterial molecules
Assignee(s)MICROSINTESIS INC.